NASDAQ · Biotechnology

Elevation Oncology, Inc. (ELEV) Stock

$0.37 -2.12% NASDAQ: ELEV Healthcare

Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles.

Valuation

MetricValue
Price$0.37
Market Cap$21.63M
P/E Ratio-0.47
P/B Ratio0.35
P/S Ratio0.00
EPS (TTM)$-0.78
52-Week High$3.09
52-Week Low$0.22
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-77.48%
ROA-46.52%
ROCE-49.04%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.52
Current Ratio21.21

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-17.0M$-32.0M$-95.0M$-45.0M$-45.0M
Net Profit$-17.0M$-32.0M$-95.0M$-46.0M$-44.0M
EPS$-0.73$-1.38$-4.09$-1.34$-0.78
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$81.0M$149.0M$94.0M$89.0M$96.0M
Total Liabilities$104.0M$9.0M$45.0M$34.0M$36.0M
Cash$79.0M$146.0M$46.0M$49.0M$49.0M
Borrowings$0$0$29.0M$30.0M$31.0M

Latest News

Molina Healthcare Earnings Beat Estimates. The Medicaid Insurer Is Confronting Investor Doubts. Barrons.com · Jul 22, 2026 Elevance Health (ELV) Stock Still Looks Reasonable After A 43% Run Simply Wall St. · Jul 22, 2026 The Hidden Engine Behind Elevance Health Stock's Next Climb Trefis · Jul 21, 2026 What Kept Coming Up When Analysts Grilled UNH Trefis · Jul 21, 2026 The Real Risk Inside UnitedHealth Stock Trefis · Jul 20, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-12.0M$-30.0M$-85.0M$-56.0M$-36.0M
Investing Cash Flow$0$0$-44.0M$12.0M$-8.0M
Financing Cash Flow$0$0$0$1.0M$1.0M
Net Cash Flow$78.0M$67.0M$-100.0M$3.0M$0
Free Cash Flow$-12.0M$-30.0M$-86.0M$-56.0M$-36.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-0.08
FCF Yield-168.14%
Quick Ratio21.21
Interest Coverage-11.18
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANPCAnPac Bio-Medical Science Co., Ltd. $4.30 -3.15% -0.54 $26.97M 0.00%
DOMH $2.45 -1.21% -2.06 $39.46M 0.00%
KAKineta, Inc. $0.57 -30.77% -0.40 $7.05M 0.00%
LSBLakeShore Biopharma Co., Ltd $0.63 +0.00% -4.51 $25.84M 0.00%
MEIPMEI Pharma, Inc. $3.07 +10.43% -1.53 $20.45M 0.00%

About Elevation Oncology, Inc.

Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.

Elevation Oncology, Inc. is headquartered in US.

Elevation Oncology, Inc. (ELEV) stock trades at $0.37 with a market capitalization of $21.63M. The stock is valued at a price-to-earnings (P/E) ratio of -0.47, price-to-book of 0.35, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.22 and $3.09, and currently trades 88.0% below its 52-week high.

On profitability, Elevation Oncology, Inc. generates a return on equity (ROE) of -77.48%, return on capital employed of -49.04%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: elevationoncology.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides